Medis Suite MR is an CMR image post-processing software for the assessment of the heart and greater vessels in both scientific research and in clinical routine. The Medis Suite MR solution offers 2D, 3D, and 4D analysis of Function, Tissue Characterization, and Flow on the Medis Suite platform. Medis Suite MR includes AI based contour detection.
Product specifications Information source: Vendor
Last updated: Sept. 16, 2021
General
Product name Medis Suite MR
Company Medis Medical Imaging
Subspeciality Cardiac
Modality MR
Disease targeted heart failure, ischemic heart disease, myocardial infarction, cardiomyopathies, myocarditis, valvular heart disease, cardiac mass, pericardial disease, atrial fibrillation, congenital heart disease
Key-features volume quantification, strain quantification, function assessment, flow quantification, infarct quantification and segmentation, T1 mapping, T2 Mapping, ECV mapping, perfusion assessment, 4D flow visualization
Suggested use During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion
Data characteristics
Population All cardiac MR scan
Input Cardiac MR from 1.5T and 3.0T machines
Input format DICOM
Output Table of quantified values, normal values, bull's eye plots, draft report, snapshot of images
Output format DICOM Secondary Capture (single-frame), DICOM Secondary Capture (multi-frame), DICOM PDF, DICOM SR, XML, Json
Technology
Integration Integration RIS (Radiological Information System), Stand-alone third party application
Deployment Locally on dedicated hardware, Locally virtualized (virtual machine, docker)
Trigger for analysis Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc.
Processing time
Certification
CE
Certified, Class IIa , MDD
FDA
510(k) cleared, Class II
Market presence
On market since 1994
Distribution channels Direct sales and distribution partners
Countries present (clinical, non-research use) The Netherlands (HQ), Germany, United Kingdom, USA, Japan, France, Spain, Portugal, Italy, Poland, Iran, Mexico, Cono Sur, Middle East, India, Iran, South East Asia, Australia, New Zealand, China, South Korea
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model Subscription, One-off payment
Based on Number of users
Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers